Superworth

Amgen PE ratio AMGN

Share price divided by earnings per share over the last twelve months, since 2010.

Today, Oct 23, 2026
27.3×
10-year median
21.1×
Against its 10-year history
79th
percentile: 0 is its lowest day, 100 its highest
10-year range
13.3× to 74.4×
Peer median
42.7×

Amgen's PE ratio is 27.3× as of Oct 23, 2026: a share price of $439.26 against $16.09 of earnings per share over the last twelve months.

That is above its ten-year median of 21.1×, higher than on 79% of days in the last ten years.

Over that time it ranged from 13.3× in May 2019 to 74.4× in Mar 2018.

The median for 8 large drugmakers of a similar size is 42.7×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far27.3×22.7×29.7×
202525.7×22.3×43.0×
202433.6×20.7×58.1×
202320.5×14.7×22.1×
202221.1×19.1×25.1×
202123.2×18.3×23.4×
202018.5×14.6×20.7×
201918.5×13.3×55.1×
201851.5×15.7×74.4×
201715.7×14.7×17.7×
201614.6×13.5×18.6×
201519.4×18.1×25.4×
201425.7×16.8×26.8×
201318.2×14.7×20.2×
201215.3×15.2×19.5×
201115.9×10.4×15.9×
201011.9×11.0×12.4×

Against its peers

Companies in Drug Manufacturers - General nearest Amgen's size, closest first, today.

CompanyPE ratio
AMGNAmgen27.3×
GILDGilead Sciencesn/m
PFEPfizer39.5×
MRKMerck116×
BMYBristol-Myers Squibb13.5×
ABBVAbbVie80.7×
JNJJohnson & Johnson40.0×
LLYEli Lilly and42.7×
BIIBBiogen44.4×
Peer median42.7×

Where Amgen ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Amgen

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.